Published in Infect Dis Obstet Gynecol on May 18, 2011
Serotyping and genotyping of genital Chlamydia trachomatis isolates reveal variants of serovars Ba, G, and J as confirmed by omp1 nucleotide sequence analysis. J Clin Microbiol (1998) 2.47
A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests. Euro Surveill (2006) 2.30
Major outer membrane protein variants of Chlamydia trachomatis are associated with severe upper genital tract infections and histopathology in San Francisco. J Infect Dis (1995) 2.12
Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States. J Bacteriol (2004) 1.94
High-resolution genotyping of Chlamydia trachomatis strains by multilocus sequence analysis. J Clin Microbiol (2007) 1.91
Characterization of Chlamydia trachomatis omp1 genotypes among sexually transmitted disease patients in Sweden. J Clin Microbiol (2001) 1.90
Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection. J Clin Microbiol (1998) 1.85
Characterization of ompA genotypes by sequence analysis of DNA from all detected cases of Chlamydia trachomatis infections during 1 year of contact tracing in a Swedish County. J Clin Microbiol (2004) 1.68
Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations? J Clin Microbiol (2000) 1.58
Longitudinal assessment of infecting serovars of Chlamydia trachomatis in Seattle public health clinics: 1988-1996. Sex Transm Dis (2003) 1.54
Chlamydia trachomatis genotypes: correlation with clinical manifestations of infection and patients' characteristics. Clin Infect Dis (1998) 1.48
The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection. Sex Transm Dis (2003) 1.46
Highly discriminative genotyping of Chlamydia trachomatis using omp1 and a set of variable number tandem repeats. Clin Microbiol Infect (2008) 1.30
Emergence and spread of Chlamydia trachomatis variant, Sweden. Emerg Infect Dis (2008) 1.30
High-resolution genotyping of Chlamydia trachomatis from recurrent urogenital infections. J Clin Microbiol (2000) 1.28
Population-based genetic epidemiologic analysis of Chlamydia trachomatis serotypes and lack of association between ompA polymorphisms and clinical phenotypes. Microbes Infect (2006) 1.15
Chlamydia trachomatis immunotypes in Finland. Acta Pathol Microbiol Immunol Scand B (1987) 1.12
Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity. J Infect Dis (2010) 1.09
A new genetic variant of Chlamydia trachomatis. Sex Transm Infect (2007) 1.08
Chlamydia trachomatis reinfection rates among female adolescents seeking rescreening in school-based health centers. Sex Transm Dis (2008) 1.02
Development of real-time PCR assays for genotyping of Chlamydia trachomatis. J Clin Microbiol (2007) 1.01
Results of a Europe-wide investigation to assess the presence of a new variant of Chlamydia trachomatis. Euro Surveill (2007) 0.99
Analysis of Chlamydia trachomatis serovar distribution changes in the Netherlands (1986-2002). Sex Transm Infect (2004) 0.99
Chlamydia trachomatis OmpA genotyping as a tool for studying the natural history of genital chlamydial infection. Sex Transm Infect (2008) 0.98
Chlamydia trachomatis seropositivity is associated both with stillbirth and preterm delivery. APMIS (2000) 0.97
Experiences with the new genetic variant of Chlamydia trachomatis in Orebro county, Sweden - proportion, characteristics and effective diagnostic solution in an emergent situation. Euro Surveill (2007) 0.97
Evolutionary dynamics of ompA, the gene encoding the Chlamydia trachomatis key antigen. J Bacteriol (2009) 0.92
TaqMan assay for Swedish Chlamydia trachomatis variant. Emerg Infect Dis (2007) 0.85
Lymphogranuloma venereum in Europe, 2003-2008. Euro Surveill (2009) 0.80
Infections preceding early arthritis in southern Sweden: a prospective population-based study. J Rheumatol (2003) 1.59
Mannose-binding lectin 2 gene polymorphism in recurrent herpes simplex virus 2 infection. Hum Immunol (2009) 1.10
Mannose-receptor positive and negative mouse macrophages differ in their susceptibility to infection by Chlamydia species. Microb Pathog (2002) 1.00
Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes. Infect Immun (2002) 0.91
Chlamydia pneumoniae and severity of asthma. Scand J Infect Dis (2002) 0.89
Subtly impaired humoral immunity predisposes to frequently recurring genital herpes simplex virus type 2 infection and herpetic neuralgia. J Infect Dis (2006) 0.88
Nitric oxide synthase plays a role in Chlamydia pneumoniae-induced atherosclerosis. Cardiovasc Res (2003) 0.88
Genotyping of Chlamydia trachomatis in rectal and pharyngeal specimens: identification of LGV genotypes in Finland. Sex Transm Infect (2012) 0.87
Criteria for selective screening for Chlamydia trachomatis. Sex Transm Dis (2003) 0.87
Elevated infection parameters and infection symptoms predict an acute coronary event. Ther Adv Cardiovasc Dis (2008) 0.87
Chlamydia pneumoniae binds to the lectin-like oxidized LDL receptor for infection of endothelial cells. Microbes Infect (2011) 0.86
IFN-gamma induced persistent Chlamydia pneumoniae infection in HL and Mono Mac 6 cells: characterization by real-time quantitative PCR and culture. Microb Pathog (2004) 0.86
A discrepancy of Chlamydia trachomatis incidence and prevalence trends in Finland 1983-2003. BMC Infect Dis (2008) 0.86
Infections as a stimulus for coronary occlusion, obstruction, or acute coronary syndromes. Ther Adv Cardiovasc Dis (2009) 0.85
Chlamydia pneumoniae infection in IL-10 knock out mice: accelerated clearance but severe pulmonary inflammatory response. Microb Pathog (2008) 0.85
Mannose-binding lectin as a risk factor for acute coronary syndromes. Ann Med (2009) 0.83
The balance of serum matrix metalloproteinase-8 and its tissue inhibitor in acute coronary syndrome and its recurrence. Int J Cardiol (2012) 0.83
Gene expression signatures characterizing the development of lymphocyte response during experimental Chlamydia pneumoniae infection. Microb Pathog (2009) 0.82
DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model. Vaccine (2004) 0.82
Chlamydia-related bacteria in respiratory samples in Finland. Microbes Infect (2011) 0.81
Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells. J Cell Mol Med (2009) 0.81
Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model. Clin Diagn Lab Immunol (2003) 0.80
Chlamydia pneumoniae entry into epithelial cells by clathrin-independent endocytosis. Microb Pathog (2011) 0.80
Chlamydia trachomatis infection induces replication of latent HHV-6. PLoS One (2013) 0.80
Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts. Med Microbiol Immunol (2011) 0.80
Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serum. Scand J Infect Dis (2009) 0.79
Flotillin-1 (Reggie-2) contributes to Chlamydia pneumoniae growth and is associated with bacterial inclusion. Infect Immun (2012) 0.78
Chlamydia pneumoniae infection in polarized epithelial cell lines. Infect Immun (2010) 0.78
Dual role of infections as risk factors for coronary heart disease. Atherosclerosis (2006) 0.78
ABC-cassette transporter 1 (ABCA1) expression in epithelial cells in Chlamydia pneumoniae infection. Microb Pathog (2013) 0.77
Up-regulation of host cell genes during interferon-gamma-induced persistent Chlamydia pneumoniae infection in HL cells. J Infect Dis (2006) 0.76
Transmission of human papillomavirus DNA from patient to surgical masks, gloves and oral mucosa of medical personnel during treatment of laryngeal papillomas and genital warts. Eur Arch Otorhinolaryngol (2012) 0.76
Host cell Golgi anti-apoptotic protein (GAAP) and growth of Chlamydia pneumoniae. Microb Pathog (2012) 0.76
[Papilloma viruses on the mucous membranes]. Duodecim (2002) 0.75
Cervical nitric oxide release in Chlamydia trachomatis and high-risk human papillomavirus infection. Acta Obstet Gynecol Scand (2011) 0.75
[Update on current care guidelines. Diagnosis, treatment and follow-up of cytological changes in the cervix, vagina and vulva]. Duodecim (2010) 0.75
An increasing proportion of reported Chlamydia trachomatis infections are repeated diagnoses. Sex Transm Dis (2012) 0.75
[Update on current care guidelines: diagnosis and treatment of sexually transmitted infections]. Duodecim (2010) 0.75
Human Herpes Virus 7 in a Patient with Recurrent Vulvar Ulceration. Acta Derm Venereol (2016) 0.75
No evidence of acute Chlamydia pneumoniae infection in patients with Bell's palsy. Otolaryngol Head Neck Surg (2002) 0.75
Systemic and mucosal antibody response in experimental Chlamydia pneumoniae infection of mice. Comp Med (2006) 0.75
[Changing epidemiological profile and treatment of syphilis and gonorrhea]. Duodecim (2002) 0.75
[Not Available]. Duodecim (2007) 0.75
[Fever, skin rash and blood bullae of the ears in a middle-aged woman]. Duodecim (2013) 0.75
[Not Available]. Duodecim (2006) 0.75